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Background. Depression is a common, disabling condition for which psychological treatments, in particular cognitive
behavioural therapies are recommended. Promising results in recent randomized trials have renewed interest in
behavioural therapy. This systematic review sought to identify all randomized trials of behavioural therapy for
depression, determine the eﬀect of such interventions and examine any moderators of such eﬀect.
Method. Randomized trials of behavioural treatments of depression versus controls or other psychotherapies were
identiﬁed using electronic database searches, previous reviews and reference lists. Data on symptom-level, recovery/
dropout rate and study-level moderators (study quality, number of sessions, severity and level of training) were
extracted and analysed using meta-analysis and meta-regression respectively.
Results. Seventeen randomized controlled trials including 1109 subjects were included in this meta-analysis. A
random-eﬀects meta-analysis of symptom-level post-treatment showed behavioural therapies were superior to controls
[standardized mean diﬀerence (SMD)x0.70, 95% CIx1.00 tox0.39, k=12, n=459], brief psychotherapy (SMDx0.56,
95% CIx1.0 tox0.12, k=3, n=166), supportive therapy (SMDx0.75, 95% CIx1.37 tox0.14, k=2, n=45) and equal
to cognitive behavioural therapy (SMD 0.08, 95% CIx0.14 to 0.30, k=12, n=476).
Conclusions. The results in this study indicate behavioural therapy is an eﬀective treatment for depression with
outcomes equal to that of the current recommended psychological intervention. Future research needs to address issues
of parsimony of such interventions.
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Introduction
Depression causes substantial disability, is set to
become the second largest cause of disease burden
by 2020 (WHO, 2001), aﬀects between 5% and 10% of
the population and is the third most common reason
for primary-care consultation (Singleton et al. 2001).
It is associated with signiﬁcant distress, impairment
of functioning, disturbance to interpersonal relation-
ships and an increased risk of suicide (Hirschfeld et al.
1997). Psychological treatments, particularly cognitive
behavioural therapy (CBT) are recommended to treat
depression (Hollon et al. 2002 ; NICE, 2004), however,
less than 10% of those aﬀected receive such treatment
(Singleton et al. 2001).
CBT combines both behavioural and cognitive
techniques in each treatment programme. The stan-
dard approach is Beck’s cognitive therapy (Beck, 1976)
using both behavioural and cognitive techniques to
identify, question and modify maladaptive thought
processes, life rules and core beliefs.
However, recent research has suggested that pure
behavioural models utilizing an operant conditioning
formulation to develop a structured daily action plan
may be as eﬀective as full cognitive therapy (CT)
(Jacobson & Gortner, 2000, Jacobson et al. 2001). Ferster
(1973) pioneered the early incorporation of learning
theory to the treatment of depression in the 1970s
followed by the establishment of the ‘coping with
depression’ intervention (Lewinsohn & Graf, 1973).
With the development of cognitive models, behav-
ioural interventions lost popularity, until recent re-
newed interest led to research reminding us of their
potential ( Jacobson & Gortner, 2000). The optimum
combination of behavioural and cognitive techniques
within CBT is unknown (Jacobson et al. 1996).
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Behavioural therapy (BT) may provide a more
parsimonious treatment option as it may be simpler
to deliver (Jacobson et al. 1996). If similar health out-
comes could be achieved with such a lesser ‘dose’ of
psychotherapy, service and training procedures could
be radically overhauled. Narrative reviews conducted
by advocates for behavioural approaches suggest
positive outcomes (Martell et al. 2001, Hopko et al.
2003), however, such reviews are prone to bias.
Alternatively, systematic reviews of psychotherapy
for depression have looked at behavioural interven-
tions in the context of considering the eﬀect of other
psychological approaches (Dobson, 1989; Gloaguen
et al. 1998 ; Churchill et al. 2001).
Therefore, we conducted a systematic review of
randomized controlled trials of behavioural interven-
tions for depression compared to other psychological
approaches and controls. We explored eﬀectiveness in
terms of depressive symptoms, dropout and recovery
rates.
Method
Identiﬁcation of suitable studies
We searched a range of databases from inception
to January 2006 (Medline, EMBASE, PsycINFO,
Cochrane Library DARE, CINAHL, AMED and the
British Nursing Index), incorporating randomized
controlled trial ﬁlters. We reviewed reference lists of
identiﬁed studies to ﬁnd additional trials. Two authors
(D.E. and D.R.) considered abstracts and screened
the full text of selected studies for relevance.
Inclusion criteria
We included all available randomized controlled
trials in any language to reduce the potential for
publication bias (Khan & Kleijnen, 2002). Studies
included participants who were adults (aged o16
years), treated in community or in-patient settings
with a primary diagnosis of depression. We excluded
studies including participants with psychosis or bi-
polar disorder, substance misuse problems, cognitive
impairment or without depression as primary diag-
nosis. We included trials of individual time-limited
behaviourally orientated psychotherapeutic ap-
proaches to the treatment of depression with an
alternative psychotherapy, control with conﬁrmation
of randomized allocation.
BT
We included trials in the behavioural inter-
vention group if the treatment was based upon the
rescheduling of activities to reintroduce positive re-
inforcement and reduce avoidance. Such interventions
manipulate the behavioural consequence of a trigger
(environmental or cognitive) rather than directly in-
terpret or restructure cognitions.
Comparators
Treatment as usual/control. A range of standard treat-
ments or non-treatment options (waiting list, usual
general practitioner treatment, inert control con-
ditions) delivered to the patient in the absence of
any ‘active’ psychotherapy.
CBT/CT. Interventions that directly identiﬁed, ques-
tioned and modiﬁed cognitive responses to situations
and their emotional consequences. We included any
intervention conceptualized as an intervention to
directly challenge thinking including ‘thought catch-
ing’ and ‘challenging’ through diary-keeping or be-
havioural experiments.
Brief psychotherapy. Approaches that focused on de-
veloping insight and subsequent character develop-
ment through interpersonal relationships with the
therapist, including brief interpersonal therapy (IPT;
Klerman et al. 1984) or brief psychodynamic therapy
(Luborsky et al. 1995).
Supportive counseling. We included any approach
which focused upon the therapist’s use of core
relationship conditions (Rogers, 1961) to develop
self-awareness by the patient.
We excluded marital, couple or group therapy as
the change in therapist contact coupled with other
group-member interaction would introduce substan-
tial clinical heterogeneity and was outside the aims
of this review.
Outcome measures
Our primary outcome measure was depression
symptom-level self-rated [e.g. Beck Depression
Inventory (BDI) ; Beck et al. 1961] or clinician-rated
[e.g. Hamilton Depression Rating Scale (HAMD);
Hamilton 1960], presented by means and standard
deviations (continuous data) or clinical improvement/
non-clinical improvement (dichotomous data). As
psychotherapy trials often present multiple symptom
measures we adopted an algorithm so that vali-
dated self-report measures took precedence over
clinician-rated measures and performed sensitivity
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analysis to explore the impact of this approach. We
entered recovery and dropout rates as dichoto-
mous data, dropout being viewed as a proxy for
acceptability.
Quality assessment
Two authors (D.E. and D.R.) rated study quality
using criteria to explore bias (Khan et al. 2002).
Other than concealment of allocation, clear guidance
on aspects of study quality that directly inﬂuence
outcomes is unclear (Jadad et al. 1996 ; Schultz &
Grimes, 2002). We assessed studies against two
standards each relating to selection, measurement,
performance and attrition bias resulting in an over-
all score of between 1 and 8. Disagreements re-
garding study quality were dealt with through
discussion.
Data extraction and synthesis
We extracted data from each trial at post-treatment
and follow-up (6 months or nearest available dataset).
We synthesized data using the Cochrane collaboration
RevMan program (Cochrane Collaboration, 2003). We
sought missing data from study authors by email.
We imputed missing standard deviation (S.D.) scores
from other relevant studies where these data were
not available following the above procedure
(Furukawa et al. 2006).
Data pooling
We combined continuous data to estimate the
standardized mean diﬀerence (SMD) across trials to
facilitate analysis of the same outcome (depression
symptom level) using diﬀerent scales as a
standardized unit (SMD). Where studies included
two comparisons under the same category (i.e. CT
and CBT) we entered these comparisons separately
but halved numbers in the behavioural arm to
avoid double counting and inaccurate weighting of
trials. Where studies presented results using sub-
categories (e.g. high/low depression severity),
we entered data as two separate trials, provided
that stratiﬁcation occurred prior to randomization.
We assigned eﬀect sizes according to the standard
convention where the SMD is small (0–0.32), me-
dium (0.33–0.55) and large (o0.56) (Lipsey &
Wilson, 1993). We present dichotomous data for
dropout and recovery rate as odds ratios (OR),
which demonstrates the chance of an event (im-
provement or dropout) in the intervention group
compared to the comparison group. We present
pooled data with 95% conﬁdence intervals (CI)
using a random-eﬀects model (Sutton et al. 1998)
taking into account both within- and between-study
variance. We consider such a model as appropriate
based upon anticipated heterogeneity for this re-
view (number of sessions, therapy approaches and
setting, etc.).
Exploration of heterogeneity
We measured statistical heterogeneity using the
I2 statistic for statistical variation across studies
(Higgins et al. 2003) ; values of 25% are low, 50%
moderate and 75% high.
Three sources of clinical and statistical hetero-
geneity were identiﬁed a priori : (1) baseline severity of
depression ; (2) training level of the therapist (graduate
versus postgraduate/experienced therapist qualiﬁ-
cation) ; (3) number of sessions. We considered study
quality as a source of potential heterogeneity, by
assessing the impact of lower quality studies on over-
all outcomes ; using a cut-point of 6 on the 8-point
quality scale.
We explored the impact of these sources of
heterogeneity using sensitivity analyses and meta-
regression (Thompson & Higgins, 2002). We ana-
lysed outcomes using meta-regression, specifying
sources of heterogeneity as predictive covariates.
We used a permutation test (using 1000 Monte-
Carlo simulations) to calculate p values, and to
reduce spurious false-positive ﬁndings (Higgins &
Thompson, 2004). The amount of heterogeneity ex-
plained by predictive covariates was examined by
reductions in the I2 inconsistency statistic within
our model. Analyses were conducted using the METAN
and METAREG commands in Stata 8 (Stata Corpor-
ation, 2003).
The possibility of publication bias was assessed
through a Begg funnel plot graph (Begg, 1994) and
testing for asymmetry using the Egger weighted re-
gression test (Egger et al. 1997) where the intercept
is 0 if no bias is present.
Results
Searches conducted between December 2005 and
February 2006 identiﬁed 3353 studies (see Fig. A1
for study ﬂow chart ; available in online Ap-
pendix). We identiﬁed 20 randomized controlled
trials (Table 1), three of which were excluded from
the meta-analysis [18–20] due to insuﬃcient re-
ported data. (Note : throughout the following sec-
tions numbers within square brackets refer to the
Study numbers listed in Table 1.) We meta-analysed
the remaining studies which included 1109 subjects
(Table 2).
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Table 1. List of studies included in review
Study no. (ﬁrst-named
author and year)
Sample/setting
Mean age [S.D. (range)]
Sex (% female) Interventions (n in cell) Depression level at baseline
Concurrent
pharmacology
Therapist level
Session number (duration)
[1] Taylor (1977) University students
22.4 (2.6)
71
Behavioural (7)
Cognitive (7)
Cognitive behavioural (7)
Wait list (7)
Mild/moderate
(21.2 BDI)
No Graduate student experience as
counsellor
6 (40 min)
[2] McLean (1979) Community out-patient
39.2 (10.9)
72
Behavioural (42)
Brief psychotherapy (44)
Drug therapy (49)
Relaxation (43)
Within or beyond moderate
depression range 2 out of
3 measures used at baseline
No (other than
DT arm)
Licensed psychologists, physicians or
psychiatrists. At least 2 years
of experience as therapist
10 (1 h) not drug therapy
[3] Gallagher (1982) Older adult community
67.76 (6)
76
Behavioural therapy (10)
Cognitive therapy (10)
Psychotherapy (10)
RDC Criteria MDD No Advanced Ph.D. or post-doctoral
therapists experience in modality
16 (90 min)
[4] Maldonado
Lopez (1982)
Community out-patient
N.A.
N.A.
Behavioural (8)
Cognitive (8)
Drug therapy (8)
Psychiatrist Diagnosis reactive
depressive disorder
No (other than
DT arm)
Psychology Dept, level of training not
reported
10 (1 h)
[5] Wilson (1982) General population media
announcements
38.8 (20–55)
66
Drug therapy & Behavioural (12)
Drug therapy & Relaxation (10)
Drug therapy &Minimal contact (10)
Placebo & Behavioural (9)
Placebo & Relaxation (11)
Placebo & Minimal contact (12)
BDI>19 In DT arm Graduate psychologist
7 (1 h)
2 (1 h) in min contact arm
[6] Wilson (1983) General population media
announcements
39.5 (20–58)
80
Behavioural (8)
Cognitive (8)
Wait list (9)
BDI>17 (moderate
depression)
Yes (5 subjects in
trial)
Not clear, University Psychology Clinic
8 (1 h)
[7] Cole (1983) Community out-patient
veterans
56 (24–71)
Behavioural (15)
Treatment as usual (15)
Psychiatrist Diagnosis major
depression.
BDI>24
Yes if stable Doctoral clinical psychology student
7 (1 h)
[8] Maldonado
Lopez (1984)
Community out-patients
N.A.
N.A.
Behavioural & Pharmacology (8)
Cognitive & Pharmacology (8)
Pharmacology (8)
Psychiatrist Diagnosis reactive
depressive disorder
All subjects Psychology Dept, level of training not
reported
10 (1 h)
[9] Skinner (1984) Community volunteers
20–61 (34)
67.5
Behavioural (8)
Cognitive(7)
Control (9)
BDI>12 Yes Doctoral clinical psychology student
5 (1 h)
[10] McNamara
(1986)
University students
23 (19–31)
73
Behavioural (10)
Cognitive (10)
Cognitive behavioural (10)
Supportive (10)
BDI>17
HAMD>20
Not reported Doctoral interns in clinical psychology/
masters-level social worker
8 (50 min) (10 sessions in CBT arm)
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[11] Thompson (1987) Older adults community
67.07 (5.8)
67
Behavioural (25)
Cognitive (27)
Psychotherapy (24)
Delayed (19)
RDC MDD If stable dose for
3 months
Doctoral-level psychologists plus 1 year
specialized therapy training
16–20 (duration of each session not
reported)
[12] Scogin (1989) Older adults community
68.3 (6.7)
85
Behavioural bibliotherapy (23)
Cognitive bibliotherapy (22)
Delayed (22)
>9 on HAMD If stabilized prior
to trial
N.A. as bibliotherapy was main
intervention
4 (5 min) phone contacts to support
exercises
[13] Jacobson (1996) Community (80% HMO,
20% volunteer)
38 (not reported)
72
Behavioural (56)
Thought challenging (43)
Full cognitive (50)
Major depression
(DSM-IV)>19 BDI
No Experienced therapists (mean 9.5 years
CT practice)
20 sessions (N.A.)
[14] McKendree
Smith (1998)
Community volunteer
44.88 (13.17)
75
Behavioural bibliotherapy (13)
Cogntive bibliotherapy (13)
Delayed control (14)
Mild-moderate
depression
If stabilized for 3
months
N.A. as Bibliotherapy main intervention
8 (10 min)
[15] Hopko (2003a) In-patients
30.5 (9)
36
Behavioural (10)
Supportive (15)
Principle diagnosis of major
depression
Yes all patients Not clear
6 (20 min)
[16] Dimidjian
(2006)
Community
39.9 (10.97)
66
Behavioural (43)
Cognitive (45)
Pharmacology/Placebo (153)
Major depression
(DSM-IV)>19 BDI
Only in ADM
arm
BA-licensed psychologists/social
worker (7 years practice.
CT-licensed psychologists with CT
training
24 (50 min)
[17] Cullen (2006) Community
38.48 (12.69)
32
Behavioural (13)
Wait list (12)
MDD (Mean BDI)
30.96 (5.90)
Yes if stable>6
weeks
Previous exp. in CT of depression plus
12 h training in BA
10 (50)
Studies not included in meta-analysis
[18] Padﬁeld (1976) Community female rural
low socio-economic status
21–56
100
Behavioural (12)
Supportive (12)
Moderately depressed
(diagnostic tool not clear)
No Counsellor (experience not clear)
12 (N.A.)
[19] Zeiss (1979) Community
33.9 (19–68)
N.A.
Behavioural (22)
Cognitive (22)
Interpersonal (22)
Classed as depressed using
Minnesota Multiphasic
Personality Inventory &
Grinkler Interview Rating
Not clear Graduate students in clinical psychology
& counselling psychologists (masters
level). At least 1 year experience
12 (N.A.)
[20] Gardner (1981) Community
19–65
77%
Behavioural (8)
Cognitive (8)
Mild depression (BDI) Not clear Not clear
N.A.
ADM, Antidepressant medication ; BT, behavioural therapy ; BDI, Beck Depression Inventory ; CBT, cognitive behavioural therapy ; CT, cognitive therapy ; DT, drug therapy ;
HAMD, Hamilton Depression Rating Scale ; HMO, health maintenance organization ; MDD, major depressive disorder ; n.a., not available ; RDC, research diagnostic criteria.
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Comparison 1: Behavioural interventions versus
waiting list/placebo control
Scope
Twelve studies with a total of 459 patients contributed
data to this analysis [1, 2, 4–7, 9, 11, 12, 14, 16, 17].
Participants were taken from adult community
sources consisting of out-patients [2, 4, 6, 7, 11, 12, 16,
17], volunteers [5, 8, 14] and students [1], two studies
used older adults [11, 12]. Control interventions
consisted of delayed treatment [1, 3, 9, 11, 12, 14, 16,
17], treatment as usual [4, 5, 7] and relaxation [2, 5].
All comparisons were taken immediately after inter-
vention. Interventions ranged from supported bib-
liotherapy [12, 14], brief therapy with six 40-min
sessions [1] to 24 50-min sessions [16]. Facilitators were
advanced graduate psychology/therapy students in
ﬁve studies [1, 5, 6, 7, 9], experienced psychotherapists
in four studies [2, 11, 16, 17] and unclear in one study
[4]. Depression symptom level was assessed using
Table 2.Meta-analyses of studies examining the eﬀects of behavioural therapy
Comparison
No. of
studies
No. of
subjects SMD 95% CI p I2
BT versus Control/TAU
Symptom level 12 459 x0.70 x1.00 tox0.39 <0.001 55.1%
Dropouta 3 119 0.58 0.28 to 1.20 0.86 0%
Recovery ratea 3 167 4.18 1.14 to 15.28 0.03 52.6%
BT versus CT/CBT
Symptom-level post-treatment 12 476 0.08 x0.14 to 0.30 0.46 21.1%
Symptom-level follow-up 8 271 0.25 x0.21 to 0.70 0.28 60.2%
Dropouta 8 436 1.17 0.57 to 2.41 1.17 32.4%
Recovery ratea 5 346 0.92 0.59 to 1.44 0.92 0%
BT versus Brief psychotherapy
Symptom-level post-treatment 3 166 x0.56 x1.0 tox0.12 0.01 43.4%
Symptom-level follow-up 2 96 x0.50 x0.90 tox0.09 0.02 0%
Dropouta 3 166 0.94 0.22 to 3.96 0.11 54.1%
Recovery ratea 3 164 2.37 1.23 to 4.57 0.01 0%
BT versus Supportive therapy
Symptom-level post-treatment 2 45 x0.75 x1.37 tox0.14 0.02 0%
BT, Behavioural therapy; CBT, cognitive behavioural therapy ; CT, cognitive therapy ; CI, conﬁdence interval ; SMD,
Standardized mean diﬀerence ; TAU, treatment as usual.
a Indicates odds ratio.
Review: Behavioural Activation for Depression
Comparison: 04 Behavioural vs control                                                                                     
Outcome: 01 SMD all studies BT vs Waitlist/Placebo Control/TAU                                                         
Study (first-named author)  Behavioural  Wait List  SMD (random)  SMD (random)
or sub-category n Mean (S.D.) n Mean (S.D.)  95% CI  95% CI
Wilson (1982) (relax)            6             12.42 (9.38)                                10              8.50 (6.35)           0.49 (–0.54 to 1.52)       
Wilson (1983)                    8               7.50 (4.55)                                  9            21.44 (5.52)         –2.60 (–3.98 to –1.22)      
Taylor (1977)                  7             10.70 (5.00)                                  7            20.10 (5.80)         –1.63 (–2.89 to –0.36)      
McLean (1979)                  42               9.70 (8.00)                                43            14.95 (8.00)         –0.65 (–1.09 to –0.21)      
Maldonado Lopez (1982)            8               7.38 (3.74)                                  8            17.63 (8.33)         –1.50 (–2.65 to –0.35)      
Wilson (1982)                    6             12.42 (9.38)                                10            14.60 (9.73)         –0.21 (–1.23 to 0.80)       
Wilson (1982) (PLA)              5             11.89 (10.87)                              12           1 4.67 (11.12)        –0.24 (–1.29 to 0.81)       
Wilson (1982) (PLA/re)            4             11.89 (10.87)                              10            16.55 (10.36)        –0.42 (–1.59 to 0.76)       
Cole (1983)                     15             26.40 (8.00)                                15            31.20 (8.00)         –0.58 (–1.32 to 0.15)       
Skinner (1984)                   8             14.62 (5.90)                                  9           1 8.33 (4.92)         –0.65 (–1.64 to 0.33)       
Thompson (1987)                30             12.40 (7.80)                                19            22.48 (7.82)         –1.27 (–1.90 to –0.64)      
Scogin (1989)                   19               9.70 (5.70)                                21            15.90 (6.90)         –0.96 (–1.61 to –0.30)      
McKendree Smith (1998)          13             12.00 (13.15)                              14            14.79 (9.63)         –0.24 (–0.99 to 0.52)       
Cullen (2006)                    6               3.83 (3.31)                                  8            28.25 (16.31)        –1.81 (–3.13 to –0.49)      
Dimidjian (2006)               22             16.82 (8.56)                                31            22.50 (12.97)        –0.49 (–1.05 to 0.06)       
Dimidjian (2006) (ls)          15             15.33 (10.03)                              19            14.68 (7.81)           0.07 (–0.61 to 0.75)       
Total (95% CI)    214                                                              245     –0.70 (–1.00 to –0.39)
Test for heterogeneity: χ 2 = 31.54, df = 15 (p = 0.007), I2 = 52.4%
Test for overall effect: Z = 4.50 (p < 0.00001)
 Favours Behavioural  Favours control
–4 –2 20 4
Fig. 1. Behavioural therapy (BT) versus wait list/control/placebo symptom-level post-treatment.
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either BDI self-report measure [1, 2, 4, 5, 7, 9, 17] or
the HAMD assessor rating scale [12], or both [6, 11, 14,
16]. Recovery was deﬁned by clinical interview in one
study [11] and by BDI score in two studies [2, 14].
Outcome 1 : Depression symptom level post-treatment
The eﬀect of behavioural interventions against control
interventions was large with a pooled SMD of x0.70
(95% CIx1.00 tox0.39), demonstrating a highly sig-
niﬁcant diﬀerence in symptom-level scores favouring
the behavioural group (p<0.001) (Fig. 1). There was
no evidence of publication bias for this outcome
(Eggers test x1.04 ; 95% CI x3.39 to 1.29, p=0.35),
a funnel plot showed no evidence of asymmetry
(Fig. 2).
Heterogeneity and sensitivity analysis
Variation in eﬀect size (I2) attributable to heterogeneity
was 55.1%. Eﬀect size was not signiﬁcantly related
to the level of baseline severity (meta-regression
b-coeﬃcient 0.04, 95% CI x0.04 to 0.12 ; I2=54%,
p=0.28) (Fig. A2 online). Quality assessment indicated
seven studies fell below our quality threshold [1, 4–7,
9, 14], and the pooled SMD was not aﬀected by
study quality (meta-regression SMDlow quality=x0.67 ;
SMDhigher quality=x0.75, pdiﬀerence=0.77). Behavioural
therapists with graduate and postgraduate qualiﬁ-
cations produced similar eﬀect sizes (meta-
regression SMDgraduate=x0.82 ; SMDpostgraduate=
x0.59, pdiﬀerence=0.61 ; I2=59%). There was no clear
relationship between eﬀect size and number of
sessions (meta-regression b-coeﬃcient 0.03 ; 95%CI
x0.03 to 0.09 ; I2=0.49, p=0.27) (Fig. A3 online).
Prioritizing clinician-rated assessment in precedence
over self-rated where possible made no signiﬁcant
diﬀerence to overall eﬀect size (SMD x0.68, 95% CI
x0.98 tox0.38).
Outcome 2: Dropout rate
Three studies contributed data to this analysis [2, 14,
16] on a total of 119 subjects with an average dropout
rate of 19.17%. We found no diﬀerence between rates
of dropout between intervention and control (OR 0.58,
95% CI 0.28–1.20, p=0.86).
Heterogeneity and sensitivity analysis
Variation in eﬀect size (I2) attributable to heterogeneity
was 0%. There were insuﬃcient studies and negligible
heterogeneity to explore the impact of our a priori
sources of clinical heterogeneity.
Outcome 3: Recovery rate
Three studies contributed data to this analysis [2,
11, 14] on a total of 167 subjects. There were greater
rates of recovery in the behavioural intervention
group (BT 52%, control 21.05%) with an odds ratio
of 4.18 (95% CI 1.14–15.28, p=0.03). There were
insuﬃcient studies to test for publication bias for this
outcome.
Heterogeneity and sensitivity analysis
Variation in eﬀect size attributable to heterogeneity
(I2) was 52.6%. Low-quality studies [14] were ex-
cluded in a sensitivity analysis resulting in an odds
ratio of 8.56 (95% CI 0.40–182.63, p=0.04) with an I2
statistic of 76.4%. There were insuﬃcient studies to
explore the underlying causes of this heterogeneity
further.
Comparison 2: BT versus CT/CBT
Scope
Twelve studies with a total of 476 patients contributed
data to this analysis [1, 3, 4, 6, 8–14, 16]. Participants
were taken from adult community sources consist-
ing of out-patients [3, 4, 8, 11–13, 16], volunteers [6, 9,
14] and students [1, 10], with three studies using
older adults [3, 11, 12]. Interventions ranged from
supported bibliotherapy [12, 14], brief therapy with
six 40-min sessions [1] to 24 50-min sessions [16].
Therapy was facilitated by advanced graduate psy-
chology/therapy students in four studies [1, 6, 9, 10],
experienced psychotherapists in four studies [3, 11,
13, 16] and was unclear in two studies [4, 7].
Depression symptom level was assessed using either
the BDI self-report measure [1, 4, 8–10] or the HAMD
assessor rating scale [12], or both [3, 6, 11, 13, 14, 16].
Recovery was deﬁned by diagnostic interview in
two studies [3, 11] and by BDI score in three studies
[10, 13, 16].
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Fig. 2. Begg funnel plot symptom level : behavioural
therapy versus control interventions/usual care.
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Outcome 1 : Depression symptom level post-treatment
No diﬀerence in eﬀect between behavioural inter-
ventions and CBT/CT was identiﬁed with a pooled
SMD of 0.08 (95% CI x0.14 to 0.30, p=0.46) (see
Fig. 3). There was no evidence of publication bias
for this outcome using Egger’s test [intercept (0 if
unbiased)=1.07 ; 95% CI x0.23 to 2.38, p=0.10],
and a funnel plot showed no evidence of asymmetry.
Heterogeneity and sensitivity analysis
Variation in eﬀect size (I2) attributable to heterogeneity
was 21.1%. Seven studies fell below our quality
threshold [1, 4, 6, 7, 9, 10, 14] and the pooled SMD
was not signiﬁcantly aﬀected by study quality (meta-
regression SMDlow quality=+0.23 ; SMDhigher quality=
x0.13, pdiﬀerence=0.12 ; I2=0%). Comparative eﬀec-
tiveness of BT versus CT/CBT varied according to
baseline severity of depression, BT demonstrating a
greater level of eﬀectiveness at more severe levels
of depression (meta-regression b-coeﬃcient x0.05,
95%CI x0.10 to x0.01 ; I2=0%, p=0.04) (Fig. A4
online).
Graduate-level behavioural therapists produced
slightly worse results compared to those with post-
graduate qualiﬁcations in comparison to CBT,
although this did not reach signiﬁcance (meta-
regression SMDgraduate=0.28 ; SMDpostgraduate=
x0.135, pdiﬀerence=0.11 ; I2=0%). There was no clear
relationship between eﬀect size and number of
sessions (meta-regression b-coeﬃcient x0.025, 95%
CI x0.056 to 0.006; I2=0.08, p=0.11). Prioritizing
clinician-rated assessment in precedence over self-
rated where possible made no signiﬁcant diﬀer-
ence in overall eﬀect size (SMD 0.09, 95% CIx0.12 to
0.29).
Outcome 2: Depression symptom level at follow-up
Eight studies contributed data to this analysis [1, 3, 4,
6, 8, 10, 12, 13] on a total of 271 subjects with an aver-
age follow-up period of 4 months. Overall there was
no diﬀerence in eﬀect of BT compared to CBT/CTwith
a pooled SMD of 0.25 (95% CIx0.21 to 0.70, p=0.28)
(Fig. 3).
Heterogeneity and sensitivity analysis
Variation in eﬀect size (I2) attributable to heterogeneity
was 60.2%. After exclusion of low- quality studies
[1, 4, 6, 8, 10] and those with follow-up of<3 months
[1, 6] in a sensitivity analysis the pooled SMD was
x0.11 (95% CI x0.41 to 0.19, p=0.47). There were
insuﬃcient studies to explore the underlying causes
of this heterogeneity further.
Outcome 3: Dropout rate
Eight studies contributed data to this analysis [1, 3, 6,
11–14, 16] on a total of 436 subjects with an average
dropout rate of 15.36%. We found no diﬀerence in
rates of dropout with an odds ratio of 1.17 (95% CI
0.57–2.41, p=0.67).
Review: Behavioural Activation for Depression
Comparison: 06 SMD BT vs CBT                                                                                              
Outcome: 01 BT vs CT Symptom Level                                                                                     
Study (first-named author)  Behavioural therapy  Cognitive therapy  SMD (random)  SMD (random)
or sub-category n Mean (S.D.) n Mean (S.D.)  95% CI  95% CI
01 Symptom-Level post-treatment
Wilson (1983)               8              7.50 (4.55)                                   8               9.00 (6.82)         –0.24 (–1.23 to 0.74)       
Taylor (1977)               4            10.70 (5.00)                                   7             10.30 (2.60)           0.10 (–1.13 to 1.33)       
Taylor (1977) (CBT)         3            10.70 (5.00)                                   7               5.60 (4.70)           0.96 (–0.49 to 2.42)       
Gallagher (1982)            10            12.62 (11.97)                               10               9.71 (5.74)           0.30 (–0.59 to 1.18)       
Maldonado Lopez (1982)       8              7.38 (3.74)                                   8               4.88 (3.80)           0.63 (–0.38 to 1.64)       
Maldonado Lopez (1984)       8            16.35 (5.37)                                   8               6.37 (7.81)           1.41 (0.28 to 2.54)        
Skinner (1984)              8            14.62 (5.90)                                   7             15.00 (7.40)         –0.05 (–1.07 to 0.96)       
McNamara (1986)             5              5.50 (3.56)                                 10               6.50 (4.17)         –0.24 (–1.31 to 0.84)       
MvNamara (1986) (CBT)       5              5.50 (3.56)                                 10               4.80 (3.55)           0.19 (–0.89 to 1.26)       
Thompson (1987)           30            12.40 (7.80)                                 31             13.60 (10.10)        –0.13 (–0.63 to 0.37)       
Scogin (1989)              19              9.70 (5.70)                                 21               7.50 (3.60)           0.46 (–0.17 to 1.09)       
Jacobson (1996)           28              9.10 (7.90)                                 50             10.10 (9.60)         –0.11 (–0.57 to 0.35)       
Jacobson (1996)  (AT)      28              9.10 (7.90)                                 43             10.60 (9.30)         –0.17 (–0.65 to 0.31)       
McKendree Smith (1998)     13            12.00 (13.15)                               13               5.62 (4.33)           0.63 (–0.16 to 1.42)       
Dimidjian (2006)          16              8.75 (7.96)                                 18             17.44 (15.57)        –0.67 (–1.37 to 0.02)       
Dimidjian (2006) (ls)     15            11.00 (10.08)                               17               9.76 (8.15)           0.13 (–0.56 to 0.83)       
Subtotal (95% CI)    208                                                              268       0.08 (–0.14 to 0.30)
Test for heterogeneity: χ2 = 19.01, df = 15 (p = 0.21), I 2  = 21.1%
Test for overall effect: Z = 0.75 (p = 0.46)
02 Symptom-level follow-up
Gallagher (1982)                      9              9.89 (9.47)                                 10               9.78 (5.67)           0.01 (–0.89, 0.91)       
Scogin (1989)                      14              9.10 (6.30)                                 15               8.90 (6.00)           0.03 (–0.70, 0.76)       
Jacobson (1996)                   25              8.50 (7.60)                                 47             10.30 (8.60)         –0.22 (–0.70, 0.27)       
Jacobson (1996)  (AT)              25              8.50 (7.60)                                 39               9.30 (8.20)         –0.10 (–0.60, 0.40)       
Subtotal (95% CI)     73                                                               111     –0.11 (–0.41, 0.19)
Test for heterogeneity: χ2 = 0.40, df = 3 (p = 0.94), I 2 = 0%
Test for overall effect: Z = 0.71 (p = 0.47)
 Favours BT  Favours CT
–4 –2 2 40
Fig. 3. Behavioural therapy (BT) versus cognitive behavioural therapy (CBT) symptom-level post-treatment and follow-up.
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Heterogeneity and sensitivity analysis
Variation in eﬀect size attributable to heterogeneity
(I2) was 32.4%. Low-quality studies [1, 6, 14] were
excluded in a sensitivity analysis resulting in an odds
ratio of 1.47 (95% CI 0.60–3.61, p=0.40) with an I2
statistic of 42.9%. There were insuﬃcient studies to
explore the underlying causes of this heterogeneity
further.
Outcome 4 : Recovery rate
Five studies contributed data to this analysis [3, 10, 11,
13, 16] on a total of 346 subjects. We found a pooled
recovery rate of 55% with no diﬀerence between
the two treatment approaches (OR 0.92, 95% CI
0.59–1.44, p=0.72).
Heterogeneity and sensitivity analysis
Variation in eﬀect size attributable to heterogeneity
(I2) was 0%. Low-quality studies [8] were excluded
in a sensitivity analysis resulting in an odds ratio of
0.93 (95% CI 0.59–1.47, p=0.77) with an I2 statistic
of 0%.
Comparison 3: Behavioural interventions versus
brief psychotherapy
Scope
Three studies with a total of 166 patients contri-
buted data to this analysis [2, 3, 11]. Participants
were from adult out-patient community sources,
two studies using older adults [3, 11]. Brief psycho-
therapy interventions were based upon a psycho-
dynamic model in all studies. Interventions ranged
from 10 to 20 sessions, all studies used experienced
therapists. Studies assessed depression symptom
level using the BDI alone [2] or both BDI and HAMD
[3, 11]. Two studies assessed depression at intake
using structured clinical interviews [3, 11], the third
using cut-oﬀ points from validated self-report
measures [2]. Recovery was deﬁned by clinical inter-
view in two studies [3, 11] and by BDI score in one
study [2].
Outcome 1 : Depression symptom post-treatment
The positive eﬀect of BT against brief psychotherapy
was large with a pooled SMD ofx0.56 (95% CIx1.0
to x0.12, p=0.01). There were insuﬃcient studies
to test for publication bias.
Heterogeneity and sensitivity analysis
Variation in eﬀect size attributable to heterogeneity
(I2) was 43.4%. All studies were above the quality
threshold, hence we performed no sensitivity
analyses. There were insuﬃcient studies to explore
the underlying causes of this heterogeneity further.
Prioritizing clinician- rated assessment in precedence
to self-rated assessment where possible made no
diﬀerence in overall eﬀect size (SMD x0.52, 95% CI
x1.01 tox0.03).
Outcome 2: Depression symptom level follow-up
Two studies contributed data to this analysis [2, 3] on
a total of 96 subjects with an average follow-up
period of 4.5 months. The positive eﬀect of behav-
ioural interventions against brief psychotherapy was
medium with a SMD of x0.50 (95% CI x0.90 to
x0.09, p=0.02).
Heterogeneity and sensitivity analysis
Variation in eﬀect size attributable to hetero-
geneity (I2) was 0%. Both studies collected follow-
up beyond the 3-month point and were above the
quality threshold so we performed no sensitivity
analyses.
Outcome 3: Dropout
Three studies contributed data to this analysis [2, 3, 11]
on a total of 166 subjects with an average dropout rate
of 14.45% across studies. No diﬀerence in dropout
was observed with an odd ratio of 0.94 (95% CI
0.22–3.96, p=0.11). There were insuﬃcient studies
to test for publication bias.
Heterogeneity and sensitivity analysis
Variation in odds ratio attributable to hetero-
geneity (I2) was 54.1%. All studies were above the
quality threshold so no sensitivity analysis was per-
formed.
Outcome 4: Recovery rate
Three trials contributed data to this analysis [2, 3, 11]
on a total of 164 subjects (note two subjects deceased).
Greater rates of recovery were observed in BT
(56.79%) compared to brief psychotherapy (36.14%)
with an odds ratio of 2.37 (95% CI 1.23–4.57, p=0.01).
There were insuﬃcient trials to test for publication
bias.
Heterogeneity and sensitivity analysis
Variation in odds ratio attributable to hetero-
geneity (I2) was 0%. All studies were above the
quality threshold so no sensitivity analysis was per-
formed.
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Comparison 4: Behavioural interventions versus
supportive therapy
Scope
Two studies with 45 subjects contributed data to this
analysis [10, 15]. Participants were university students
[10] and in-patients [15].
Interventions ranged from six 20-min sessions [10]
to eight, 50-min sessions [15], delivered by doctoral
clinical psychology students [10] or a clinical psy-
chologist [15]. Both studies measured depression
symptom levels by self-report measures (BDI), with
one [10] using HAMD also. Depression at baseline
was assessed by self-report measures [10] or clinical
interview [15].
Outcome 1 : Depression symptom level post-treatment
The positive eﬀect of BT against supportive therapy
was large (SMD x0.75, 95% CI x1.37 to x0.14,
p=0.02). There were insuﬃcient studies to test for
publication bias.
Heterogeneity and sensitivity analysis
The variation in eﬀect size attributable to heterogen-
eity (I2) was 0%. Both studies fell below the quality
threshold therefore no sensitivity analysis was per-
formed. Insuﬃcient data were available in this
comparison for further analysis.
Discussion
We found clear evidence that BT is an eﬀective treat-
ment for depression. It provides superior outcomes to
control, supportive counselling and brief psycho-
therapy. BT and CBT provided equivalent results with
no statistically signiﬁcant diﬀerences in post-treatment
and follow-up symptom levels, in recovery rate or
dropouts.
The BT trials were variable in design and delivery.
To some degree, we have been able to utilize this
variability to explore factors relating to magnitude of
eﬀectiveness. Such meta-regression analysis makes
observational associations and is exploratory in
nature and as such loses the power of causal inference
(Higgins & Thompson, 2004). We considered such an
approach viable and eﬃcient in this review as the
alternative of planning large-scale prospective trials
with many arms is costly and time consuming.
Suﬃcient data for this analysis were available only
where BT was compared to controls or CT/CBT post-
treatment on symptom level. Our meta-regression
found that compared to controls, baseline severity,
length of treatment and level of qualiﬁcation were
not related to BT eﬀect although there is a positive
relationship between greater baseline severity and
BT eﬃcacy compared to CT/CBT. Such ﬁndings
provide direction in the development of BT for future
research. They indicated that further exploration is
needed into length of treatment and skill level re-
quired for optimum BT delivery. Our review ident-
iﬁed a number of trials directly comparing BT with
drug therapy; this was not included as an a priori
comparator. Such a comparison would be a useful
addition in any future review as BT would appear
equivalent, if not superior, to pharmacology in the
included studies.
Our meta-analysis complements and concurs
with other publications that include behavioural in-
terventions as part of wider CBT reviews (Dobson,
1989 ; Gloaguen et al. 1998 ; Churchill et al. 2001),
or focus on activation alone (Cuijpers et al. 2007). In
contrast to these previous reviews we chose to focus
on individual rather than group interventions, and
included dropout and recovery rate analyses. Our
review includes more studies than previous reviews
due to our broader inclusion criteria and the inclusion
of recent and unpublished data. The studies drew
patients from a range of settings such as in-patient,
psychiatric out-patient and volunteer cohorts in
adult, older adult and student settings. Interventions
varied considerably across studies from supported
self-help using minimal therapist contact to full
psychotherapy. The quality of included trials varied
considerably, with some of low quality delivering
results that deviated considerably from the overall
picture [4, 8]. We attempted to account for this by the
use of sensitivity analysis, random-eﬀects modelling
and meta-regression of a priori variables. Interpret-
ation of our results must be made with such factors
in mind. Caution must also be exercised in inter-
preting the comparisons of behavioural interventions
with brief psychotherapy and supportive therapy
due to the low numbers of studies and small sample
sizes.
Of particular interest is the observed equivalence
between behavioural interventions and the CBT/CT
strongly recommended in guidelines (e.g. NICE,
2004). In addition to similar levels of mean symptom
improvement, we observed no diﬀerence in recovery
or dropout. These combined ﬁndings indicate that
behavioural interventions are as eﬀective and accept-
able as CBT/CT. Such ﬁndings partially endorse the
BT parsimony hypothesis advanced by Jacobson and
colleagues (Jacobson et al. 1996, 2001). They question
the utility of adding ‘complex’ cognitive techniques to
simpler behavioural interventions to improve clinical
outcome. One of the attractions of behavioural inter-
ventions is that they may lend themselves to shorter
training of less-qualiﬁed individuals, thus assisting
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the current scarcity of therapist availability and
overwhelming demand (Centre for Economic Per-
formance’s Mental Health Policy Group, 2006). We
found no direct evidence in this review to support
such an assumption, as we found no studies using
non-psychology- or non-psychotherapy-trained in-
dividuals delivering BT. However, when we examined
the impact on level of training of those who had de-
livered BT in meta-regression, we did not ﬁnd that
superior outcomes were associated with ‘higher
level ’ qualiﬁcations. Such ﬁndings may support the
assertion that BT may be suitable for shorter training
and hence improve access by increasing available
therapists within limited resources. We recommend
further research of this question based upon our
ﬁndings.
In summary, BT for depression is an eﬀective
intervention that has equal, if not better, outcomes
than alternative and currently recommended thera-
pies. Our review adds to the literature in the area as it
provides a broad overview of the current evidence,
reports data on recovery, dropout and explores the
eﬀect of baseline covariants in relation to depression
symptom change. We recommend further research
into the eﬃcacy of behavioural treatments of de-
pression, in particular Jacobson et al.’s (1996) parsi-
mony hypothesis where the intervention is delivered
by ‘technicians’ rather than therapists.
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